Cargando…
mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence
Fragile X syndrome (FXS) is caused by silencing of the human FMR1 gene and is the leading monogenic cause of intellectual disability and autism. Abundant preclinical data indicated that negative allosteric modulators (NAMs) of metabotropic glutamate receptor 5 (mGluR5) might be efficacious in treati...
Autores principales: | Stoppel, David C., McCamphill, Patrick K., Senter, Rebecca K., Heynen, Arnold J., Bear, Mark F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511445/ https://www.ncbi.nlm.nih.gov/pubmed/34658956 http://dx.doi.org/10.3389/fpsyt.2021.718953 |
Ejemplares similares
-
Contribution of mGluR5 to hippocampal pathophysiology in a mouse model of human chromosome 16p11.2 microdeletion
por: Tian, Di, et al.
Publicado: (2015) -
Analysis of the Gut Microbiota and Inflammatory Factors in mGluR5-Knockout Mice
por: Cai, Guohong, et al.
Publicado: (2020) -
Disrupted mGluR5-Homer scaffolds mediate abnormal mGluR5 signaling, circuit function and behavior in a mouse model of Fragile X Syndrome
por: Ronesi, Jennifer A., et al.
Publicado: (2012) -
Characterization of a mGluR5 Knockout Rat Model with Hallmarks of Fragile X Syndrome
por: Dahl, Victoria, et al.
Publicado: (2022) -
Combination Therapy in Fragile X Syndrome; Possibilities and Pitfalls Illustrated by Targeting the mGluR5 and GABA Pathway Simultaneously
por: Zeidler, Shimriet, et al.
Publicado: (2017)